CYTK Cytokinetics
$61.35 -2.15%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.15%
YTD
+2.00%
P/E
—
P/B
15.68
ROE
-131.2%
Div yield
—
Beta
0.8
Market cap
$9.0B
RSI (14)
25
Next earnings
Oct 29, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$62.20
Close
$61.35
VWAP (n/a)
—
Day high
$62.53
Day low
$60.68
Volume
3.2M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
Yahoo Finance · Oct 2
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Yahoo Finance · Sep 30
Cytokinetics Maps MYQORZO Expansion, Heart Failure Pipeline at Bernstein Conference
Yahoo Finance · Sep 25
Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?
Yahoo Finance · Sep 23
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · Sep 17
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
Yahoo Finance · Sep 14
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 28, 2026 View → 8-K Aug 13, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K May 27, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell CYTK. Try it in the Lab to size a position and see the risk.